Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury

Lee,Jae-Won; Park,Ji-Won; Shin,Na-Rae; Park,So-Yeon; Kwon,Ok-Kyoung; Park,Hyun  Ah; Lim,Yourim; Ryu,Hyung  Won; Yuk,Heung  Joo; Kim,Jung  Hee; Oh,Sei-Ryang; Ahn,Kyung-Seop

doi:10.3892/ijmm.2016.2669

Picrasma quassiodes (D. Don) Benn. attenuates lipopolysaccharide (LPS)-induced acute lung injury

Authors:
- Jae-Won Lee
- Ji-Won Park
- Na-Rae Shin
- So-Yeon Park
- Ok-Kyoung Kwon
- Hyun Ah Park
- Yourim Lim
- Hyung Won Ryu
- Heung Joo Yuk
- Jung Hee Kim
- Sei-Ryang Oh
- Kyung-Seop Ahn
View Affiliations

Affiliations: Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju-si, Chungbuk 363‑883, Republic of Korea
Published online on: July 7, 2016 https://doi.org/10.3892/ijmm.2016.2669
Pages: 834-844

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Picrasma quassiodes (D.Don) Benn. (PQ) is a medicinal herb belonging to the family Simaroubaceae and is used as a traditional herbal remedy for various diseases. In this study, we evaluated the effects of PQ on airway inflammation using a mouse model of lipopolysaccharide (LPS)-induced acute lung injury (ALI) and LPS-stimulated raw 264.7 cells. ALI was induced in C57BL/6 mice by the intranasal administration of LPS, and PQ was administered orally 3 days prior to exposure to LPS. Treatment with PQ significantly attenuated the infiltration of inflammatory cells in the bronchoalveolar lavage fluid (BALF). PQ also decreased the production of reactive oxygen species (ROS) and pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6 in BALF. In addition, PQ inhibited airway inflammation by reducing the expression of inducible nitric oxide synthase (iNOS) and by increasing the expression of heme oxygenase-1 (HO-1) in the lungs. Furthermore, we demonstrated that PQ blocked the activation of mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) in the lungs of mice with LPS-induced ALI. In the LPS-stimulated RAW 264.7 cells, PQ inhibited the release of pro-inflammatory cytokines and increased the mRNA expression of monocyte chemoattractant protein-1 (MCP-1). Treatment with PQ decreased the translocation of nuclear factor (NF)-κB to the nucleus, and increased the nuclear translocation of nuclear factor erythroid-2-related factor 2 (Nrf2) and the expression of HO-1. PQ also inhibited the activation of p38 in the LPS-stimulated RAW 264.7 cells. Taken together, our findings demonstrate that PQ exerts anti-inflammatory effects against LPS-induced ALI, and that these effects are associated with the modulation of iNOS, HO-1, NF-κB and MAPK signaling. Therefore, we suggest that PQ has therapeutic potential for use in the treatment of ALI.

View Figures

View References

1	Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005. View Article : Google Scholar : PubMed/NCBI
2	Zhang Y, Liang D, Dong L, Ge X, Xu F, Chen W, Dai Y, Li H, Zou P, Yang S and Liang G: Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury. Respir Res. 16:432015. View Article : Google Scholar :
3	Shin NR, Shin IS, Song HH, Hong JM, Kwon OK, Jeon CM, Kim JH, Lee SW, Lee JK, Jin H, et al: Callicarpa japonica Thunb. reduces inflammatory responses: a mouse model of lipopolysaccharide-induced acute lung injury. Int Immunopharmacol. 26:174–180. 2015. View Article : Google Scholar : PubMed/NCBI
4	Sun XJ, Li XQ, Wang XL, Tan WF and Wang JK: Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccharide-induced acute inflammatory lung injury via toll-like receptor 4 signaling. PLoS One. 10:e01227522015. View Article : Google Scholar
5	Huang X, Tang J, Cai H, Pan Y, He Y, Dai C, Chen A, Yu X, Chen M, Zou L and Wang L: Anti-inflammatory effects of monoammonium glycyrrhizinate on lipopolysaccharide-induced acute lung injury in mice through regulating nuclear factor-kappa B signaling pathway. Evid Based Complement Alternat Med. 2015:2724742015. View Article : Google Scholar : PubMed/NCBI
6	Auten RL, Whorton MH and Nicholas Mason S: Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol. 26:391–397. 2002. View Article : Google Scholar : PubMed/NCBI
7	Grommes J, Vijayan S, Drechsler M, Hartwig H, Mörgelin M, Dembinski R, Jacobs M, Koeppel TA, Binnebösel M, Weber C and Soehnlein O: Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation. PLoS One. 7:e389172012. View Article : Google Scholar : PubMed/NCBI
8	Farley KS, Wang LF, Law C and Mehta S: Alveolar macrophage inducible nitric oxide synthase-dependent pulmonary microvascular endothelial cell septic barrier dysfunction. Microvasc Res. 76:208–216. 2008. View Article : Google Scholar : PubMed/NCBI
9	Wang L, Taneja R, Razavi HM, Law C, Gillis C and Mehta S: Specific role of neutrophil inducible nitric oxide synthase in murine sepsis-induced lung injury in vivo. Shock. 37:539–547. 2012. View Article : Google Scholar : PubMed/NCBI
10	Beck-Schimmer B, Schwendener R, Pasch T, Reyes L, Booy C and Schimmer RC: Alveolar macrophages regulate neutrophil recruitment in endotoxin-induced lung injury. Respir Res. 6:612005. View Article : Google Scholar : PubMed/NCBI
11	Takashima K, Matsushima M, Hashimoto K, Nose H, Sato M, Hashimoto N, Hasegawa Y and Kawabe T: Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury. Respir Res. 15:1502014. View Article : Google Scholar : PubMed/NCBI
12	Grommes J and Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med. 17:293–307. 2011. View Article : Google Scholar :
13	Yang H, Li Y, Huo P, Li XO, Kong D, Mu W, Fang W, Li L, Liu N, Fang L, et al: Protective effect of Jolkinolide B on LPS-induced mouse acute lung injury. Int Immunopharmacol. 26:119–124. 2015. View Article : Google Scholar : PubMed/NCBI
14	Akbarshahi H, Rosendahl AH, Westergren-Thorson G and Anderson R: Acute lung injury in acute pancreatitis - awaiting the big leap. Respir Med. 106:1199–1210. 2012. View Article : Google Scholar : PubMed/NCBI
15	Chi G, Wei M, Xie X, Soromou LW, Liu F and Zhao S: Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Inflammation. 36:501–511. 2013. View Article : Google Scholar
16	Huang GJ, Deng JS, Chen CC, Huang CJ, Sung PJ, Huang SS and Kuo YH: Methanol extract of Antrodia camphorata protects against lipopolysaccharide-induced acute lung injury by suppressing NF-κB and MAPK pathways in mice. J Agric Food Chem. 62:5321–5329. 2014. View Article : Google Scholar : PubMed/NCBI
17	Yeh CH, Yang JJ, Yang ML, Li YC and Kuan YH: Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway. Free Radic Biol Med. 69:249–257. 2014. View Article : Google Scholar : PubMed/NCBI
18	Lee JW, Kwon JH, Lim MS, Lee HJ, Kim SS, Lim SY and Chun W: 3,4,5-Trihydroxycinnamic acid increases heme-oxygenase-1 (HO-1) and decreases macrophage infiltration in LPS-induced septic kidney. Mol Cell Biochem. 397:109–116. 2014. View Article : Google Scholar : PubMed/NCBI
19	Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS, Lee HJ, Kim SS and Chun W: 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in vitro and improves survival of mice in LPS-induced endotoxemia model in vivo. Mol Cell Biochem. 390:143–153. 2014. View Article : Google Scholar : PubMed/NCBI
20	Yin H, Li X, Gong Q, Jin X, Gu H, Yuan B, Zhang B, Zheng F, Gong F and Zhu J: Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor. Mol Immunol. 47:2443–2449. 2010. View Article : Google Scholar : PubMed/NCBI
21	Hashiba T, Suzuki M, Nagashima Y, Suzuki S, Inoue S, Tsuburai T, Matsuse T and Ishigatubo Y: Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Ther. 8:1499–1507. 2001. View Article : Google Scholar : PubMed/NCBI
22	Zhao W, Yu J, Su Q, Liang J, Zhao L, Zhang Y and Sun W: Antihypertensive effects of extract from Picrasma quassiodes (D. Don) Benn. in spontaneously hypertensive rats. J Ethnopharmacol. 145:187–192. 2013. View Article : Google Scholar
23	Zhao W, Sun C, He J, Chen L, Zhang Y and Sun W: The possible mechanisms of Picrasma quassiodes (D. Don) Benn. in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in mice. J Ethnopharmacol. 145:424–430. 2013. View Article : Google Scholar
24	Zhang Q, Shu X, Jing F, Wang X, Lin C and Luo A: Preparative separation of alkaloids from Picrasma quassioides (D. Don) Benn. by conventional and pH-zone-refining countercurrent chromatography. Molecules. 19:8752–8761. 2014. View Article : Google Scholar : PubMed/NCBI
25	Fan H, Qi D, Yang M, Fang H, Liu K and Zhao F: In vitro and in vivo anti-inflammatory effects of 4-methoxy-5-hydroxycanthin-6-one, a natural alkaloid from Picrasma quassioides. Phytomedicine. 20:319–323. 2013. View Article : Google Scholar
26	Shin NR, Shin IS, Jeon CM, Hong JM, Oh SR, Hahn KW and Ahn KS: Inhibitory effects of Picrasma quassioides (D. Don) Benn. on airway inflammation in a murine model of allergic asthma. Mol Med Rep. 10:1495–1500. 2014.PubMed/NCBI
27	Liu YL, Liu YJ, Liu Y, Li XS, Liu SH, Pan YG, Zhang J, Liu Q and Hao YY: Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways. Int Immunopharmacol. 23:649–657. 2014. View Article : Google Scholar : PubMed/NCBI
28	Farley KS, Wang LF, Razavi HM, Law C, Rohan M, McCormack DG and Mehta S: Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 290:L1164–L1172. 2006. View Article : Google Scholar : PubMed/NCBI
29	Deshmane SL, Kremlev S, Amini S and Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 29:313–326. 2009. View Article : Google Scholar : PubMed/NCBI
30	Takahashi M, Galligan C, Tessarollo L and Yoshimura T: Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A. J Immunol. 183:3463–3471. 2009. View Article : Google Scholar : PubMed/NCBI
31	Cheung DW, Koon CM, Wat E, Ko CH, Chan JY, Yew DT, Leung PC, Chan WY, Lau CB and Fung KP: A herbal formula containing roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages through inhibition of nuclear factor κB (NFκB) pathway. J Ethnopharmacol. 145:776–783. 2013. View Article : Google Scholar
32	Kim KH, Kwun MJ, Han CW, Ha KT, Choi JY and Joo M: Suppression of lung inflammation in an LPS-induced acute lung injury model by the fruit hull of Gleditsia sinensis. BMC Complement Altern Med. 14:4022014. View Article : Google Scholar : PubMed/NCBI
33	Wang F, Meng Y, Zhang Y, Zhao G, Zheng X, Xiao Q and Yu Y: Ketamine reduces lipopolysaccharide-induced high-mobility group box-1 through heme oxygenase-1 and nuclear factor erythroid 2-related factor 2/p38 mitogen-activated protein kinase. J Surg Res. 194:599–613. 2015. View Article : Google Scholar : PubMed/NCBI
34	Liu KD and Matthay MA: Advances in critical care for the nephrologist: acute lung injury/ARDS. Clin J Am Soc Nephrol. 3:578–586. 2008. View Article : Google Scholar : PubMed/NCBI
35	Jin S, Merchant ML, Ritzenthaler JD, McLeish KR, Lederer ED, Torres-Gonzalez E, Fraig M, Barati MT, Lentsch AB, Roman J, et al: Baclofen, a GABABR agonist, ameliorates immune-complex mediated acute lung injury by modulating pro-inflammatory mediators. PLoS One. 10:e01216372015. View Article : Google Scholar : PubMed/NCBI
36	Johnson ER and Matthay MA: Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv. 23:243–252. 2010. View Article : Google Scholar : PubMed/NCBI
37	Corteling R, Wyss D and Trifilieff A: In vivo models of lung neutrophil activation. Comparison of mice and hamsters. BMC Pharmacol. 2:12002. View Article : Google Scholar : PubMed/NCBI
38	Liu XX, Yu DD, Chen MJ, Sun T, Li G, Huang WJ, Nie H, Wang C, Zhang YX, Gong Q and Ren BX: Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release. Int Immunopharmacol. 25:370–376. 2015. View Article : Google Scholar : PubMed/NCBI
39	Guo L, Li S, Zhao Y, Qian P, Ji F, Qian L, Wu X and Qian G: Silencing angiopoietin-like protein 4 (ANGPTL4) protects against lipopolysaccharide-induced acute lung injury via regulating SIRT1/NF-kB pathway. J Cell Physiol. 230:2390–2402. 2015. View Article : Google Scholar : PubMed/NCBI
40	Fu K, Piao T, Wang M, Zhang J, Jiang J, Wang X and Liu H: Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 23:400–406. 2014. View Article : Google Scholar : PubMed/NCBI
41	Zhang SY, Xu LT, Li AX and Wang SM: Effects of ergosterol, isolated from Scleroderma Polyrhizum Pers., on lipopolysaccharide-induced inflammatory responses in acute lung injury. Inflammation. 38:1979–1985. 2015. View Article : Google Scholar : PubMed/NCBI
42	Chen T, Mou Y, Tan J, Wei L, Qiao Y, Wei T, Xiang P, Peng S, Zhang Y, Huang Z and Ji H: The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 25:55–64. 2015. View Article : Google Scholar : PubMed/NCBI
43	Zhang WZ, Jiang ZK, He BX and Liu XB: Arctigenin protects against lipopolysaccharide-induced pulmonary oxidative stress and inflammation in a mouse model via suppression of MAPK, HO-1, and iNOS signaling. Inflammation. 38:1406–1414. 2015. View Article : Google Scholar : PubMed/NCBI
44	Harkin DW, Rubin BB, Romaschin A and Lindsay TF: Selective inducible nitric oxide synthase (iNOS) inhibition attenuates remote acute lung injury in a model of ruptured abdominal aortic aneurysm. J Surg Res. 120:230–241. 2004. View Article : Google Scholar : PubMed/NCBI
45	Speyer CL, Neff TA, Warner RL, Guo RF, Sarma JV, Riedemann NC, Murphy ME, Murphy HS and Ward PA: Regulatory effects of iNOS on acute lung inflammatory responses in mice. Am J Pathol. 163:2319–2328. 2003. View Article : Google Scholar : PubMed/NCBI
46	Jiang T, Huang Z, Chan JY and Zhang DD: Nrf2 protects against As(III)-induced damage in mouse liver and bladder. Toxicol Appl Pharmacol. 240:8–14. 2009. View Article : Google Scholar : PubMed/NCBI
47	Shin IS, Hong J, Jeon CM, Shin NR, Kwon OK, Kim HS, Kim JC, Oh SR and Ahn KS: Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression. Food Chem Toxicol. 62:506–513. 2013. View Article : Google Scholar : PubMed/NCBI
48	Hualin C, Wenli X, Dapeng L, Xijing L, Xiuhua P and Qingfeng P: The anti-inflammatory mechanism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages. Inflammation. 35:1087–1093. 2012. View Article : Google Scholar
49	Han CW, Kwun MJ, Kim KH, Choi JY, Oh SR, Ahn KS, Lee JH and Joo M: Ethanol extract of Alismatis Rhizoma reduces acute lung inflammation by suppressing NF-κB and activating Nrf2. J Ethnopharmacol. 146:402–410. 2013. View Article : Google Scholar : PubMed/NCBI
50	Kung CW, Lee YM, Cheng PY, Peng YJ and Yen MH: Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats. J Surg Res. 167:e323–e331. 2011. View Article : Google Scholar : PubMed/NCBI
51	Li KC, Ho YL, Hsieh WT, Huang SS, Chang YS and Huang GJ: Apigenin-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK phosphorylation. Int J Mol Sci. 16:1736–1754. 2015. View Article : Google Scholar : PubMed/NCBI
52	San Z, Fu Y, Li W, Zhou E, Li Y, Song X, Wang T, Tian Y, Wei Z, Yao M, et al: Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice. Int Immunopharmacol. 19:342–350. 2014. View Article : Google Scholar : PubMed/NCBI
53	Sogo T, Terahara N, Hisanaga A, Kumamoto T, Yamashiro T, Wu S, Sakao K and Hou DX: Anti-inflammatory activity and molecular mechanism of delphinidin 3-sambubioside, a Hibiscus anthocyanin. Biofactors. 41:58–65. 2015. View Article : Google Scholar : PubMed/NCBI
54	Jing W, Chunhua M and Shumin W: Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro. Toxicol Appl Pharmacol. 285:128–135. 2015. View Article : Google Scholar : PubMed/NCBI